1. Of course MSB needs the funds. That's the whole point of the IPO. But they're also looking at partners AND they're currently engaged with discussions with various parties including Celgene. You don't want to negotiate partnerships if your bank balance needs topping up because it compromises your deals. The brokers' buyers are simply leveraging this. It's not optimal but it's not fatal either. How would you like to raise $70mil in the Australian biotech market right now, when the SP has already been hammered by the shorters? Macbank issued a report and then made the SP falls happen with a scare campaign. It's been highly effective so far. Posters like madamswer repeated Macbanks words almost verbatim, then we got variations on the theme. In a very small market which is easily manipulated, they've helped make it happen. What genius.
2. You mean US analysts views will mean the science is more likely to fail? No. this is getting weird. They haven't had long to come to terms with MSB and, if they aren't backing the story they might be right but I really don't think so. There are other stem cell operators in the field they might like and have already backed. I admit I thought the US might be fairer to MSB, but maybe not. This will not affect the efficacy of the science one iota.
Stay calm. (I'm beginning to get fed up with the MSB threads and that's saying a lot).
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)